Previous 10 | Next 10 |
2023-05-10 06:21:20 ET Alvotech ( NASDAQ: ALVO ) signed an exclusive agreement with Polifarma Ilac San. ve tic. for the commercialization in Turkey of AVT06, a proposed biosimilar to Regeneron Pharmaceuticals ( REGN ) and Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ...
2023-05-04 14:24:09 ET Regeneron Pharmaceuticals Inc. (REGN) Q1 2023 Results Conference Call May 04, 2023 08:30 AM ET Company Participants Ryan Crowe - Investor Relations Leonard Schleifer - Chief Executive Officer George Yancopoulos - Co-Founder, President and C...
2023-05-04 13:43:10 ET Intellia Therapeutics ( NASDAQ: NTLA ) added ~13% on Thursday to reach the highest level in more than two months after the gene-editing company reported its Q1 2023 financials alongside updates from its clinical pipeline. Notable disclosures include In...
2023-05-04 13:23:55 ET Regeneron Pharmaceuticals (NASDAQ: REGN) , a large-cap biotechnology company, is under heavy pressure today. Specifically, the biotech's stock was down by an unsightly 6.5% on heavy volume as of 12:19 p.m. ET Thursday afternoon. Regeneron's shares are ...
2023-05-04 07:29:02 ET Regeneron Pharmaceuticals' ( NASDAQ: REGN ) stock is trading in the red premarket on Thursday after net product sales of Eylea in the U.S. fell. even as the company's Q1 results beat estimates. Worldwide sales of wet AMD drug Eylea — developed w...
2023-05-04 06:32:01 ET Regeneron Pharmaceuticals press release ( NASDAQ: REGN ): Q1 Non-GAAP EPS of $10.09 beats by $0.53 . Revenue of $3.16B (+6.4% Y/Y) beats by $160M . First quarter 2023 Dupixent ® global net sales (recorded by Sanofi)...
2023-05-03 13:37:49 ET Regeneron Pharmaceuticals ( NASDAQ: REGN ) is scheduled to announce Q1 earnings results on Thursday, May 4th, before market open. The consensus EPS Estimate is $9.56 (-16.8% Y/Y) and the consensus Revenue Estimate is $3B (+1.0% Y/Y). Over the las...
Oral presentations include interim results from pivotal trial of linvoseltamab (BCMAxCD3) in relapsed/refractory multiple myeloma and three cohorts of fianlimab (LAG-3 inhibitor) combined with Libtayo ® (cemiplimab-rwlc) in advanced melanoma Ten total presentations to c...
2023-04-28 15:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-27 06:08:25 ET Sanofi ( NASDAQ: SNY ) Q1 profit rose beating estimates as blockbuster drug Dupixent performed well again. Business EPS rose +11.3% Y/Y on a reported basis (+11.9% at constant exchange rates, or CER) to €2.16. Q1 sales grew +5.7% Y/Y (+5.5% CER)...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...